ANTIVIRAL PILLS For COVID-19: What you need to know

Share

How Antiviral treatments for COVID-19 compare: The latest Data based on publications from both Pfizer & Merck about their oral antiviral treatments that can be taken from home.


References:

PFIZER’S NOVEL COVID-19 ORAL ANTIVIRAL TREATMENT CANDIDATE REDUCED RISK OF HOSPITALIZATION OR DEATH BY 89% IN INTERIM ANALYSIS OF PHASE 2/3 EPIC-HR STUDY: https://www.pfizer.com/news/press-rel…

Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study: https://www.merck.com/news/merck-and-…

Pfizer Soars After Covid Pill Shows Strong Results in Study: https://www.bloomberg.com/news/articl…

Why New Pills to Treat Covid Could Be Game Changers: QuickTake: https://www.bloomberg.com/news/articl…

What are protease inhibitors for HIV?: https://www.medicalnewstoday.com/arti…

Science Brief: COVID-19 Vaccines and Vaccination: https://www.cdc.gov/coronavirus/2019-…

Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021: https://www.cdc.gov/mmwr/volumes/70/w…